US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

Watchlist
  • 0.378
  • -0.002-0.59%
15min DelayClose May 14 16:00 ET
2.59MMarket Cap-56P/E (TTM)

Agile Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
80.02%19.59M
-9.56%3.61M
121.92%6.66M
158.84%5.5M
116.52%3.81M
165.40%10.88M
163.94%4M
133.26%3M
79.41%2.13M
1,418.10%1.76M
Operating revenue
80.02%19.59M
-9.56%3.61M
121.92%6.66M
158.84%5.5M
116.52%3.81M
165.40%10.88M
163.94%4M
133.26%3M
79.41%2.13M
1,418.10%1.76M
Cost of revenue
31.33%8.98M
32.55%2.19M
73.82%2.48M
3.41%2.31M
31.17%2M
-36.22%6.84M
-71.01%1.65M
-47.44%1.43M
94.85%2.23M
31.52%1.53M
Gross profit
162.23%10.62M
-39.27%1.42M
165.38%4.19M
3,143.81%3.2M
673.50%1.81M
161.18%4.05M
155.96%2.34M
210.74%1.58M
-362.50%-105K
122.39%234K
Operating expense
-32.94%30.5M
-40.62%5.48M
-10.67%8.19M
-26.31%8.32M
-46.11%8.52M
-29.36%45.48M
-49.25%9.22M
-36.15%9.16M
-32.34%11.29M
4.15%15.81M
Selling and administrative expenses
-33.05%28.27M
-38.88%5.42M
-10.69%7.48M
-27.00%7.62M
-46.70%7.76M
-27.37%42.23M
-46.23%8.87M
-34.35%8.38M
-34.06%10.44M
11.46%14.55M
-Selling and marketing expense
-41.49%17.77M
-45.53%3.73M
-13.67%4.8M
-38.33%4.57M
-55.75%4.67M
-30.10%30.37M
-48.06%6.85M
-40.76%5.56M
-38.12%7.41M
14.05%10.55M
-General and administrative expense
-11.42%10.51M
-16.36%1.69M
-4.80%2.68M
0.76%3.05M
-22.82%3.09M
-19.31%11.86M
-38.92%2.02M
-16.49%2.82M
-21.44%3.03M
5.16%4M
Research and development costs
-31.60%2.23M
-84.66%54K
-10.53%705K
-17.87%703K
-39.30%763K
-47.92%3.25M
-79.02%352K
-50.53%788K
-0.70%856K
-40.79%1.26M
Operating profit
52.01%-19.88M
41.09%-4.05M
47.27%-4M
55.03%-5.13M
56.93%-6.71M
41.65%-41.43M
69.24%-6.88M
51.91%-7.59M
31.55%-11.4M
4.00%-15.57M
Net non-operating interest income expense
56.05%-1.34M
28.36%-288K
65.76%-328K
56.52%-357K
57.63%-369K
21.55%-3.05M
59.76%-402K
4.01%-958K
16.73%-821K
3.86%-871K
Non-operating interest income
-2.50%78K
-43.33%17K
-71.74%13K
650.00%15K
3,200.00%33K
220.00%80K
2,900.00%30K
4,500.00%46K
-71.43%2K
-93.75%1K
Non-operating interest expense
-54.68%1.42M
-29.40%305K
-66.04%341K
-54.80%372K
-53.90%402K
-20.01%3.13M
-56.80%432K
0.50%1M
-17.12%823K
-5.42%872K
Other net income (expense)
-53.05%6.76M
-103.88%-130K
35.00%3.53M
-76.26%1.67M
21.89%1.69M
276.22%14.4M
3.35M
2.61M
7.05M
1.38M
Gain on sale of security
-73.51%6.76M
-103.88%-130K
-74.31%3.53M
-76.26%1.67M
21.89%1.69M
566.84%25.52M
--3.35M
--13.74M
--7.05M
--1.38M
Special income (charges)
--0
--0
--0
----
----
---11.12M
--0
---11.12M
----
----
-Gain on sale of property,plant,equipment
--0
--0
--0
----
----
---11.12M
--0
---11.12M
----
----
Income before tax
51.92%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
64.21%-5.39M
57.66%-30.09M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
12.07%-15.06M
Income tax
0
0
0
0
0
-4.68M
0
0
0
-4.68M
Net income
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
39.37%-10.39M
Net income continuous Operations
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
39.37%-10.39M
Minority interest income
Net income attributable to the parent company
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
39.37%-10.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
43.08%-14.47M
-13.71%-4.47M
86.53%-799K
26.30%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.64%-5.93M
70.70%-5.17M
39.37%-10.39M
Basic earnings per share
88.59%-6.71
71.80%-1.41
96.63%-0.27
96.25%-2.15
96.45%-5.91
95.98%-58.79
98.75%-5
97.78%-8.01
85.68%-57.29
58.33%-166.68
Diluted earnings per share
88.59%-6.71
71.80%-1.41
96.63%-0.27
96.25%-2.15
96.45%-5.91
95.98%-58.79
98.75%-5
97.78%-8.01
85.68%-57.29
58.33%-166.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 80.02%19.59M-9.56%3.61M121.92%6.66M158.84%5.5M116.52%3.81M165.40%10.88M163.94%4M133.26%3M79.41%2.13M1,418.10%1.76M
Operating revenue 80.02%19.59M-9.56%3.61M121.92%6.66M158.84%5.5M116.52%3.81M165.40%10.88M163.94%4M133.26%3M79.41%2.13M1,418.10%1.76M
Cost of revenue 31.33%8.98M32.55%2.19M73.82%2.48M3.41%2.31M31.17%2M-36.22%6.84M-71.01%1.65M-47.44%1.43M94.85%2.23M31.52%1.53M
Gross profit 162.23%10.62M-39.27%1.42M165.38%4.19M3,143.81%3.2M673.50%1.81M161.18%4.05M155.96%2.34M210.74%1.58M-362.50%-105K122.39%234K
Operating expense -32.94%30.5M-40.62%5.48M-10.67%8.19M-26.31%8.32M-46.11%8.52M-29.36%45.48M-49.25%9.22M-36.15%9.16M-32.34%11.29M4.15%15.81M
Selling and administrative expenses -33.05%28.27M-38.88%5.42M-10.69%7.48M-27.00%7.62M-46.70%7.76M-27.37%42.23M-46.23%8.87M-34.35%8.38M-34.06%10.44M11.46%14.55M
-Selling and marketing expense -41.49%17.77M-45.53%3.73M-13.67%4.8M-38.33%4.57M-55.75%4.67M-30.10%30.37M-48.06%6.85M-40.76%5.56M-38.12%7.41M14.05%10.55M
-General and administrative expense -11.42%10.51M-16.36%1.69M-4.80%2.68M0.76%3.05M-22.82%3.09M-19.31%11.86M-38.92%2.02M-16.49%2.82M-21.44%3.03M5.16%4M
Research and development costs -31.60%2.23M-84.66%54K-10.53%705K-17.87%703K-39.30%763K-47.92%3.25M-79.02%352K-50.53%788K-0.70%856K-40.79%1.26M
Operating profit 52.01%-19.88M41.09%-4.05M47.27%-4M55.03%-5.13M56.93%-6.71M41.65%-41.43M69.24%-6.88M51.91%-7.59M31.55%-11.4M4.00%-15.57M
Net non-operating interest income expense 56.05%-1.34M28.36%-288K65.76%-328K56.52%-357K57.63%-369K21.55%-3.05M59.76%-402K4.01%-958K16.73%-821K3.86%-871K
Non-operating interest income -2.50%78K-43.33%17K-71.74%13K650.00%15K3,200.00%33K220.00%80K2,900.00%30K4,500.00%46K-71.43%2K-93.75%1K
Non-operating interest expense -54.68%1.42M-29.40%305K-66.04%341K-54.80%372K-53.90%402K-20.01%3.13M-56.80%432K0.50%1M-17.12%823K-5.42%872K
Other net income (expense) -53.05%6.76M-103.88%-130K35.00%3.53M-76.26%1.67M21.89%1.69M276.22%14.4M3.35M2.61M7.05M1.38M
Gain on sale of security -73.51%6.76M-103.88%-130K-74.31%3.53M-76.26%1.67M21.89%1.69M566.84%25.52M--3.35M--13.74M--7.05M--1.38M
Special income (charges) --0--0--0-----------11.12M--0---11.12M--------
-Gain on sale of property,plant,equipment --0--0--0-----------11.12M--0---11.12M--------
Income before tax 51.92%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M64.21%-5.39M57.66%-30.09M79.87%-3.93M64.64%-5.93M70.70%-5.17M12.07%-15.06M
Income tax 00000-4.68M000-4.68M
Net income 43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M70.70%-5.17M39.37%-10.39M
Net income continuous Operations 43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M70.70%-5.17M39.37%-10.39M
Minority interest income
Net income attributable to the parent company 43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M70.70%-5.17M39.37%-10.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 43.08%-14.47M-13.71%-4.47M86.53%-799K26.30%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.64%-5.93M70.70%-5.17M39.37%-10.39M
Basic earnings per share 88.59%-6.7171.80%-1.4196.63%-0.2796.25%-2.1596.45%-5.9195.98%-58.7998.75%-597.78%-8.0185.68%-57.2958.33%-166.68
Diluted earnings per share 88.59%-6.7171.80%-1.4196.63%-0.2796.25%-2.1596.45%-5.9195.98%-58.7998.75%-597.78%-8.0185.68%-57.2958.33%-166.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg